PINKGLOW
LIVE

Serial Number

79417363

Owner

Del Monte International GmbH

Attorney

Nicole Meyer

Filing Date

Sep 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PINKGLOW Trademark

Serial Number: 79417363

PINKGLOW is a trademark filed by Del Monte International GmbH on September 19, 2024. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Del Monte International GmbH

Dammstrasse 19

Entity Type: 27

Trademark Details

Filing Date

September 19, 2024

Registration Date

Not Registered

Goods & Services

Cosmetic preparations sold as components of soaps, perfumes and eau de Cologne; perfumes; bath foams; bath oils; eaux de toilette; eau de Cologne; aftershave; after-shave balms; non-medicated face and body soaps; talcum powders

Pharmaceutical and nutraceutical preparations and substances for medical use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, diabetes, cancer, obesity and cognitive disorders and diseases and disorders of the immune system; pharmaceutical preparations and substances for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products and substances for the treatment of viral and infectious diseases; nutraceuticals used as food supplements; nutraceuticals and pharmaceutical products for the treatment of cancer, obesity, diabetes and other diseases and disorders in the nature of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, cognitive disorders and diseases and disorders of the immune system; biological preparations for the treatment of cancer, obesity, diabetes and other diseases and disorders in the nature of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, cognitive disorders and diseases and disorders of the immune system; biological reagents for medical use; nutritional supplements; bio-medicines, namely, biological preparations and substances for medical use; biomedical products, namely, biological preparations for medical purposes; biological reagents for medical use; veterinary products, namely, veterinary preparations for treating cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, diabetes, cancer, obesity and cognitive disorders and diseases and disorders of the immune system, in animals; biological preparations for veterinary use, namely, for the treatment of cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, diabetes, obesity and cognitive disorders and diseases and disorders of the immune system

Chemical products, namely, plant derived additives sold as components for use in the manufacture of cosmetic products, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; plant derived preparations used as components for use in the manufacture of cosmetic products, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; active chemical ingredients for use in the manufacture of cosmetics, moisturizing creams, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; pharmaceutical products and ingredients namely, plant derived additives and plant derived preparations for use in the manufacture of pharmaceuticals for the treatment of viral and infectious diseases

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 6, 2026 OPNX
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2026 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 20, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 19, 2026 OPNR
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jul 17, 2026 LIME
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2026 TROA
LIMITATION OF GOODS RECEIVED FROM IB
May 21, 2026 LIMG
REFUSAL PROCESSED BY IB
Dec 11, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 21, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 21, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 7, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR